1-16 of 16
John A. Colwell, MD, PHD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Aspirin for Primary Prevention of Cardiovascular Events in People With Diabetes: A position statement of the American Diabetes Association, a scientific statement of the American Heart Association, and an expert consensus document of the American College of Cardiology Foundation

Michael Pignone, MD, MPH, FACP, Mark J. Alberts, MD, John A. Colwell, MD, PHD, MACP, Mary Cushman, MD, MSC, Silvio E. Inzucchi, MD, Debabrata Mukherjee, MD, MS, FACC, Robert S. Rosenson, MD, FACC, FAHA, FACP, Craig D. Williams, PHARMD, FNLA, Peter W. Wilson, MD, M. Sue Kirkman, MD
Journal: Diabetes Care
Diabetes Care 2010;33(6):1395–1402
https://doi.org/10.2337/dc10-0555
Published: 01 June 2010
View article titled, Aspirin for Primary Prevention of Cardiovascular Events in People With Diabetes: <subtitle>A position statement of the American Diabetes Association, a scientific statement of the American Heart Association, and an expert consensus document of the American College of Cardiology Foundation</subtitle>
Open the PDF for Aspirin for Primary Prevention of Cardiovascular Events in People With Diabetes: <subtitle>A position statement of the American Diabetes Association, a scientific statement of the American Heart Association, and an expert consensus document of the American College of Cardiology Foundation</subtitle> in another window
Journal Articles

Aspirin for Primary Prevention of Cardiovascular Events in Diabetes

John A. Colwell, MD, PHD
Journal: Diabetes Care
Diabetes Care 2003;26(12):3349–3350
https://doi.org/10.2337/diacare.26.12.3349
Published: 01 December 2003
View article titled, Aspirin for Primary Prevention of Cardiovascular Events in Diabetes
Open the PDF for Aspirin for Primary Prevention of Cardiovascular Events in Diabetes in another window
Journal Articles

The Platelet in Diabetes: Focus on prevention of ischemic events

John A. Colwell, MD, PHD, Richard W. Nesto, MD
Journal: Diabetes Care
Diabetes Care 2003;26(7):2181–2188
https://doi.org/10.2337/diacare.26.7.2181
Published: 01 July 2003
View article titled, The Platelet in Diabetes: <subtitle>Focus on prevention of ischemic events</subtitle>
Open the PDF for The Platelet in Diabetes: <subtitle>Focus on prevention of ischemic events</subtitle> in another window
Journal Articles

Aspirin Therapy in Diabetes is Underutilized

John A. Colwell, MD, PHD, MACP
Journal: Diabetes Care
Diabetes Care 2001;24(2):195–196
https://doi.org/10.2337/diacare.24.2.195
Published: 01 February 2001
View article titled, Aspirin Therapy in Diabetes is Underutilized
Open the PDF for Aspirin Therapy in Diabetes is Underutilized in another window
Journal Articles

Ethnic Differences in the Glycemic Response to Exogenous Insulin Treatment in the Veterans Affairs Cooperative Study in Type 2 Diabetes Mellitus (VA CSDM)

Lily Agrawal, MD, FACE, Nicholas V Emanuele, MD, Carlos Abraira, MD, William G Henderson, PHD, Seymour R Levin, MD, Clark T Sawin, MD, Cynthia K Silbert, MD, Frank Q Nuttall, MD, PHD, John P Comstock, MD, PHD, John A Colwell, MD, PHD, VA CSDM Group
Journal: Diabetes Care
Diabetes Care 1998;21(4):510–515
https://doi.org/10.2337/diacare.21.4.510
Published: 01 April 1998
View article titled, Ethnic Differences in the Glycemic Response to Exogenous Insulin Treatment in the Veterans Affairs Cooperative Study in Type 2 Diabetes Mellitus (VA CSDM)
Open the PDF for Ethnic Differences in the Glycemic Response to Exogenous Insulin Treatment in the Veterans Affairs Cooperative Study in Type 2 Diabetes Mellitus (VA CSDM) in another window
Journal Articles

A Critical Issue: Intensive insulin treatment and macrovascular disease

Carlos Abraira, MD, John A Colwell, MD, PHD, Frank Nuttall, MD, PHD, Nicholas Emanuele, MD, John Comstock, MD, Seymour Levin, MD, Clark Sawin, MD, Cynthia Silbert, MD
Journal: Diabetes Care
Diabetes Care 1998;21(4):669–671
https://doi.org/10.2337/diacare.21.4.669
Published: 01 April 1998
View article titled, A Critical Issue: Intensive insulin treatment and macrovascular disease
Open the PDF for A Critical Issue: Intensive insulin treatment and macrovascular disease in another window
Journal Articles

Response to Intensive Therapy Steps and to Glipizide Dose in Combination With Insulin in Type 2 Diabetes: VA feasibility study on glycemic control and complications (VA CSDM)

Carlos Abraira, MD, William G Henderson, PHD, John A Colwell, MD, PHD, Frank Q Nuttall, MD, PHD, John P Comstock, MD, Nicholas V Emanuele, MD, Seymour R Levin, MD, Clark T Sawin, MD, Cynthia K Silbert, MD, VA CSDM Group
Journal: Diabetes Care
Diabetes Care 1998;21(4):574–579
https://doi.org/10.2337/diacare.21.4.574
Published: 01 April 1998
View article titled, Response to Intensive Therapy Steps and to Glipizide Dose in Combination With Insulin in Type 2 Diabetes: VA feasibility study on glycemic control and complications (VA CSDM)
Open the PDF for Response to Intensive Therapy Steps and to Glipizide Dose in Combination With Insulin in Type 2 Diabetes: VA feasibility study on glycemic control and complications (VA CSDM) in another window
Journal Articles

Elevated Plasma Homocysteine and Diabetic Vascular Disease

John A Colwell, MD, PHD
Journal: Diabetes Care
Diabetes Care 1997;20(12):1805–1806
https://doi.org/10.2337/diacare.20.12.1805
Published: 01 December 1997
View article titled, Elevated Plasma Homocysteine and Diabetic Vascular Disease
Open the PDF for Elevated Plasma Homocysteine and Diabetic Vascular Disease in another window
Journal Articles

Aspirin Therapy in Diabetes

John A Colwell, MD, PHD
Journal: Diabetes Care
Diabetes Care 1997;20(11):1767–1771
https://doi.org/10.2337/diacare.20.11.1767
Published: 01 November 1997
View article titled, Aspirin Therapy in Diabetes
Open the PDF for Aspirin Therapy in Diabetes in another window
Journal Articles

Should We Use Intensive Insulin Therapy After Oral Agent Failure in Type II Diabetes?

John A Colwell, MD, PHD
Journal: Diabetes Care
Diabetes Care 1996;19(8):896–898
https://doi.org/10.2337/diacare.19.8.896
Published: 01 August 1996
View article titled, Should We Use Intensive Insulin Therapy After Oral Agent Failure in Type II Diabetes?
Open the PDF for Should We Use Intensive Insulin Therapy After Oral Agent Failure in Type II Diabetes? in another window
Journal Articles

Release of Platelet Plasminogen Activator Inhibitor 1 in Whole Blood Is Increased in Patients With Type II Diabetes

Rudolf Jokl, MD, Richard L Klein, PHD, Maria F Lopes-Virella, MD, PHD, John A Colwell, MD, PHD
Journal: Diabetes Care
Diabetes Care 1995;18(8):1150–1155
https://doi.org/10.2337/diacare.18.8.1150
Published: 01 August 1995
View article titled, Release of Platelet Plasminogen Activator Inhibitor 1 in Whole Blood Is Increased in Patients With Type II Diabetes
Open the PDF for Release of Platelet Plasminogen Activator Inhibitor 1 in Whole Blood Is Increased in Patients With Type II Diabetes in another window
Journal Articles

Veterans Affairs Cooperative Study on Glycemic Control and Complications in Type II Diabetes (VA CSDM): Results of the feasibility trial

Carlos Abraira, MD, John A Colwell, MD, PHD, Frank Q Nuttall, MD, PHD, Clark T Sawin, MD, Nancy Johnson Nagel, PHD, John P Comstock, MD, Nicholas V Emanuele, MD, Seymour R Levin, MD, William Henderson, PHD, Hae Sook Lee, BA, VA CSDM Group
Journal: Diabetes Care
Diabetes Care 1995;18(8):1113–1123
https://doi.org/10.2337/diacare.18.8.1113
Published: 01 August 1995
View article titled, Veterans Affairs Cooperative Study on Glycemic Control and Complications in Type II Diabetes (VA CSDM): Results of the feasibility trial
Open the PDF for Veterans Affairs Cooperative Study on Glycemic Control and Complications in Type II Diabetes (VA CSDM): Results of the feasibility trial in another window
Journal Articles

Platelet Plasminogen Activator Inhibitor 1 in Patients With Type II Diabetes

Rudolf Jokl, MD, Marta Laimins, Richard L Klein, PHD, Timothy J Lyons, MD, MRCP, Maria F Lopes-Virella, MD, PHD, John A Colwell, MD, PHD
Journal: Diabetes Care
Diabetes Care 1994;17(8):818–823
https://doi.org/10.2337/diacare.17.8.818
Published: 01 August 1994
View article titled, Platelet Plasminogen Activator Inhibitor 1 in Patients With Type II Diabetes
Open the PDF for Platelet Plasminogen Activator Inhibitor 1 in Patients With Type II Diabetes in another window
Journal Articles

Is It Time To Introduce Metformin in the U.S.?

John A Colwell, MD, PHD
Journal: Diabetes Care
Diabetes Care 1993;16(4):653–655
https://doi.org/10.2337/diacare.16.4.653
Published: 01 April 1993
View article titled, Is It Time To Introduce Metformin in the U.S.?
Open the PDF for Is It Time To Introduce Metformin in the U.S.? in another window
Journal Articles

Effects of Gemfibrozil on Triglyceride Levels in Patients With NIDDM: Hyperlipidemia in Diabetes Investigators

Aaron I Vinik, MD, PHD, John A Colwell, MD, PHD
Journal: Diabetes Care
Diabetes Care 1993;16(1):37–44
https://doi.org/10.2337/diacare.16.1.37
Published: 01 January 1993
View article titled, Effects of Gemfibrozil on Triglyceride Levels in Patients With NIDDM: Hyperlipidemia in Diabetes Investigators
Open the PDF for Effects of Gemfibrozil on Triglyceride Levels in Patients With NIDDM: Hyperlipidemia in Diabetes Investigators in another window
Journal Articles

Hemostatic Alterations With Exercise Conditioning in NIDDM

W Guyto Hornsby, PhD, Karen A Boggess, MD, Timothy J Lyons, MD, William H Barnwell, MD, John Lazarchick, MD, John A Colwell, MD, PhD
Journal: Diabetes Care
Diabetes Care 1990;13(2):87–92
https://doi.org/10.2337/diacare.13.2.87
Published: 01 February 1990
View article titled, Hemostatic Alterations With Exercise Conditioning in NIDDM
Open the PDF for Hemostatic Alterations With Exercise Conditioning in NIDDM in another window